首页> 美国卫生研究院文献>Journal of Medicinal Food >Eugenia jambolana Pretreatment Prevents Isoproterenol-Induced Myocardial Damage in Rats: Evidence from Biochemical Molecular and Histopathological Studies
【2h】

Eugenia jambolana Pretreatment Prevents Isoproterenol-Induced Myocardial Damage in Rats: Evidence from Biochemical Molecular and Histopathological Studies

机译:Eugenia jambolana预处理可预防异丙肾上腺素引起的大鼠心肌损伤:来自生化分子和组织病理学研究的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Preventive effects of hydroalcoholic extract of fruit pulp of Eugenia jambolana (HEEJ) on isoproterenol (ISP)-induced myocardial damage in rats were evaluated. Rats were pre-treated with HEEJ (100, 200, and 400 mg/kg) daily for 30 days. ISP (85 mg/kg bw) was administered on the 28th and 29th days at an interval of 24 h. Ischemic control group exhibited significant increases in oxidative stress parameters, markers of inflammation, cardiac damage markers, and apoptotic markers. Oral pre-treatment with HEEJ (100, 200, and 400 mg/kg bw) provided cardioprotective activity by decreasing levels of malondialdehyde, cardiac markers (serum glutamate oxaloacetate transaminase, creatine kinase-myocardial band, cardiac troponin I), and markers of inflammation (interleukin-6, C-reactive protein, and tumor necrosis factor alpha); and increased levels of superoxide dismutase and reduced glutathione. HEEJ (400 mg/kg bw) was found to exert significantly greater effects in comparison to HEEJ (100 and 200 mg/kg bw). Apoptotic marker Bcl-2 was increased, while Bax was decreased in pre-treated rats, which was further confirmed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay. The present study provides evidence that pre-treatment with HEEJ attenuates oxidative stress, apoptosis and improves cardiac architecture in ISP-induced rats and, hence, is cardioprotective.
机译:评估了番木瓜果肉水醇提取物对异丙肾上腺素(ISP)诱导的大鼠心肌损伤的预防作用。每天用HEEJ(100、200和400μmg/ kg)对大鼠进行预处理,持续30天。在第28天和第29天以24 h的间隔给予ISP(85 mg / kg bw)。缺血对照组显示出氧化应激参数,炎症标志物,心脏损伤标志物和凋亡标志物的显着增加。口服HEEJ预处理(100、200和400μmg/ kg体重)可通过降低丙二醛,心脏标志物(血清谷氨酸草酰乙酸转氨酶,肌酸激酶-心肌带,心肌肌钙蛋白I)和炎症标志物的含量来提供心脏保护活性。 (白介素6,C反应蛋白和肿瘤坏死因子α);以及增加的超氧化物歧化酶水平和减少的谷胱甘肽。与HEEJ(100和200μmg/ kg体重)相比,HEEJ(400μmg/ kg体重)的作用明显更大。在预处理的大鼠中,凋亡标记物Bcl-2增加,而Bax减少,这通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记测定进一步证实。本研究提供证据表明,用HEEJ进行预处理可减轻ISP诱导的大鼠的氧化应激,细胞凋亡并改善心脏结构,因此具有心脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号